Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(56)
•••
Alex1726
X
View Profile
View Bullboard History
Comment by
Alex1726
on Jun 11, 2024 3:13pm
RE:AGM July 16, 2024
You're defently sick , that's a psychiatric problem and this is huge.
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 10, 2024 9:32am
AGM July 16, 2024
March 27, 2024 AEZS news release: "The Company completed enrollment of all patients in the DETECT-trial and expects that the last patient will receive the patient’s first growth hormone
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(2245)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 09, 2024 2:38pm
Down 13% since merger announced
$11.60 ---> $10.08
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 1:52pm
Heart health chewy bar - beta glucan and avenanthramide
Yes, a heart health chewy bar containing beta-glucan and avenanthramides from oats could be an interesting nutraceutical product. Here are the key points supporting this: Beneficial Compounds in
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 1:33pm
a 30-50% further reduction?
Perplexity Ai asked to guess the results from combining colchicine and avenanthramide... "A reasonable estimate could be a 30-50% further reduction in inflammation and major adverse
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 12:47pm
Avenanthramide in combination with colchicine
Yes, colchicine and avenanthramides (AVA) reduce inflammation through independent mechanisms, and combining them is likely to enhance the reduction of inflammation in treating heart disease and other
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 12:28pm
Colchicine and mortality
Perplexity Ai: Based on the search results, colchicine overdose has a high mortality rate, though the exact rate is not clearly stated.Some key points regarding the mortality rate from colchicine
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 09, 2024 11:19am
RE:Important news on inflammation and cardiovascular disease
Yes, the graph below shows a ~30-fold risk of cardiac death for 3-vessel inflammation, 13-fold for one artery, during extended follow-up
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 09, 2024 11:13am
RE:RE:Important news on inflammation and cardiovascular disease
The Dr. at the Montreal Heart Institute in charge of AEZS's avenanthramide pill clinical trial, Dr. Jean-Claude Tardif, has run clinical trials on colchicine which is the first FDA approved drug
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 09, 2024 10:57am
RE:Important news on inflammation and cardiovascular disease
Where to Go From Here The totality of these findings highlight the importance of systemic and arterial inflammation for risk of major adverse cardiovascular events. We should be using
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 10:57am
Important news on inflammation and cardiovascular disease
@EricTopol
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 09, 2024 10:43am
Osteoarthritis and avenanthramide
The high prevalence of osteoarthritis, especially in the aging population, is a major driver for the demand for NSAIDs as they are commonly prescribed for managing osteoarthritis pain and inflammation
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 08, 2024 10:07am
"transformational products"
With the merger now complete it's time to launch the company into the imagination of NASDAQ. If the world's largest biotech company said AEZS had "transtormational products" that
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 08, 2024 9:45am
Potential Breakthrough
Potential for Aeterna Zentaris's AIM Biologicals Program Aeterna Zentaris (AEZS) has been making significant progress with its AIM Biologicals program, which targets neuromyelitis optica spectrum
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 08, 2024 9:38am
Delayed Clearance Parathyroid Hormone(AEZS-150)
According to AEZS's website expected to be a $2.7 billion market by 2028. "This project aims to address this debilitating orphan disease, which is currently without satisfactory
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed